GVR Report cover Forensic Genomics Market (2026 - 2033)Report

Forensic Genomics Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product (Software, Consumables & Kits), By Method (NGS, PCR Amplification), By Application (Paternity & Familial, Criminal Testing), By Region, And Segment Forecasts

Market Size, 2025

$660.0M

Market Estimate, 2026

$755.6M

Market Forecast, 2033

$2,053.1M

CAGR, 2026–2033

15.3%

Forensic Genomics Market Size & Trends

The global forensic genomics market size was valued at USD 660.0 million in 2025 and is projected to grow from USD 755.6 million in 2026 to USD 2,053.1 million by 2033, at a CAGR of 15.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 49.7% in 2025. The growth of the industry is driven by swift technological progress, rising funding from both private and government sources aimed at developing affordable forensic testing methods, and a growing incidence of crimes, including homicides, kidnappings, and sexual assaults. 

Forensic genomics market overview: Grand View Research estimates the global market size at USD 660 billion in 2025, projected to grow from USD 755.6 billion in 2026 to USD 2053.1 billion by 2033 at a 15.3% CAGR, with regional growth momentum.

Key Market Trends & Insights

  • By product: Kits & consumables segment held the largest revenue share of over 67.2% in 2025.
  • By application: Criminal testing segment held the largest revenue share of over 66.0% in 2025.
  • By method: Capillary electrophoresis (CE) segment held the largest revenue share of over 36.6% in 2025.

Regional Highlights

  • Largest regional market: North America (49.7% revenue share, 2025)
  • Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
  • By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

  • Market size in 2025: USD 660.0 Million
  • Estimated market size in 2026: USD 755.6 Million
  • Projected market size by 2033: USD 2,053.1 Million
  • CAGR (2026-2033): 15.3%

 

For example, in January 2022, the National Institute of Justice announced USD 13 million in funding to support five projects under its research and evaluation program for testing and analyzing physical evidence in publicly funded forensic laboratories. The COVID-19 pandemic had a detrimental effect on the global industry. Local restrictions on the movement of goods have impacted the operations of forensic laboratories worldwide. Additionally, the heightened risk of contracting the SARS-CoV-2 virus when handling biological samples, such as tissues and bodily fluids, has reduced the demand for DNA forensics. Forensic investigators face an increased risk of infection since biological materials like semen, blood, saliva, and other evidence from crime scenes can carry the virus. Moreover, limited laboratory budgets have slowed the industry's growth.

Forensic genomics market size and growth forecast (2023-2033)

However, various areas within forensic science, including DNA analysis, are evolving globally. Innovative techniques are being developed, implemented, and validated to aid criminal investigations. Researchers often encounter challenges related to the validity and accuracy of both current and older methods. For example, in May 2021, Verogen Inc. partnered with the forensic division of Eurofins Scientific to launch the ForenSeq MainstAY Workflow, which aims to enhance support for sexual assault cases and volume casework.

The application of criminal testing is expected to grow rapidly in the coming years. As global crime rates rise, the demand for forensic genomics is projected to increase significantly. Statistics Canada reported approximately 743 homicide cases in 2020, with homicide rates rising by 7%, from 1.83 to 1.95 per 100,000 people—the highest level since 2005. These factors are likely to further propel market growth.

Market Dynamics

The forensic genomics market is witnessing steady growth, driven by the increasing adoption of advanced DNA analysis technologies in criminal investigations, kinship testing, missing person identification, and disaster victim identification. Rising demand for rapid, accurate, and high-throughput forensic testing, coupled with growing investments in forensic laboratories and advancements in next-generation sequencing (NGS), is supporting market expansion. Moreover, increasing government initiatives to strengthen forensic infrastructure, expanding DNA databases, and the integration of AI-driven bioinformatics tools for genomic data interpretation are expected to further support the market growth over the forecast period.

The increasing adoption of next-generation sequencing (NGS) is a major driver of the forensic genomics market, as it enables comprehensive analysis of multiple genetic markers in a single assay with greater accuracy and sensitivity than conventional capillary electrophoresis methods. NGS supports the analysis of degraded, low-template, and mixed DNA samples commonly encountered in forensic investigations, while improving human identification, kinship analysis, missing person identification, and cold case resolution. Its ability to simultaneously evaluate STRs, SNPs, and mitochondrial DNA has significantly enhanced the reliability and efficiency of forensic workflows.

The market is further supported by continuous advancements in NGS platforms and forensic genomic technologies that improve sequencing speed, throughput, and analytical performance. For instance, in June 2025, Othram expanded its forensic technology portfolio by introducing deployable AI-powered software workflows and SNP-based analysis solutions to enable broader adoption of advanced forensic genomics capabilities by laboratories and law enforcement agencies. These developments are expected to support the integration of NGS-based forensic testing and strengthen market growth over the forecast period.

Ethical and privacy concerns associated with the collection, storage, and use of forensic genetic data are a key restraint for the forensic genomics market. The expansion of DNA databases and the increasing use of genomic information in criminal investigations have raised concerns regarding data security, informed consent, unauthorized access, and potential misuse of sensitive genetic information. These issues can limit public trust and influence the adoption of forensic genomic technologies.

In addition, evolving regulations governing genetic data protection and forensic DNA databases require laboratories and law enforcement agencies to comply with stringent privacy and security standards. The need to ensure legal and ethical use of genomic information, while maintaining data integrity and confidentiality, may increase operational complexity and slow the implementation of advanced forensic genomics technologies, thereby restraining market growth over the forecast period.

 

Analyst Perspective

The forensic genomics market is expected to witness strong growth, driven by the increasing adoption of next-generation sequencing (NGS) in forensic investigations, human identification, kinship analysis, and criminal case resolution. Growing demand for highly accurate DNA analysis, coupled with advancements in sequencing technologies and bioinformatics, is enhancing the efficiency and reliability of forensic workflows. Rising government investments in forensic infrastructure, expanding DNA databases, and the increasing use of genomics in disaster victim identification and missing person investigations are expected to support long-term market growth. Market participants are focusing on innovative sequencing solutions, automation, and integrated analysis platforms to improve forensic testing accuracy and turnaround times.

Product Insights

Based on product, the kits & consumables segment held the largest revenue share of over 67.2% in 2025. It includes items such as needles, reaction tubes, clippers, pipettes, fingerprint powders, vials, labels, brushes, and crime scene kits. Factors driving the growth of this segment include the rising number of criminal investigations, increased governmental efforts to address crime case backlogs, growing awareness of DNA profiling in criminology, and investments from both public and private entities in forensic sciences.

The software segment is expected to grow at the highest CAGR from 2025 to 2033. The need for accurate and reliable forensic analysis is driving investment in software solutions that improve the efficiency and accuracy of DNA profiling and other forensic techniques. The integration of artificial intelligence and machine learning in forensic software is also revolutionizing case investigations by providing predictive analytics and pattern recognition capabilities. Moreover, regulatory requirements and the push for standardized processes in forensic labs are leading to increased adoption of software solutions that ensure compliance and quality control. These trends collectively contribute to the robust growth of the segment.

Method Insights

Based on method, the capillary electrophoresis (CE) segment held the largest revenue share of over 36.6% in 2025. Ongoing advancements and new product launches from industry players are further fueling the growth of this segment. For example, in May 2022, Promega Corporation launched the Spectrum CE System designed for forensic laboratories. This CE device offers a modern solution for forensic labs engaged in human identification for database and criminal casework, enhancing their operational efficiency.

The next-generation sequencing (NGS) segment is expected to experience the highest growth rate during the forecast period. This growth is primarily driven by NGS's cost-effectiveness and high throughput capabilities, making it a vital tool for various companies and genomic researchers. For example, in October 2020, Verogen Inc. partnered with Cellmark Forensic Services to launch an ISO17025-certified forensic NGS service in the U.K. The ForenSeq DNA Signature Prep Kit and MiSeq FGx Sequencing System from Verogen will help address complex relationship cases and investigations, providing the forensic community with enhanced phenotypic insights.

Application Insights

Based on application, the criminal testing segment held the largest revenue share of over 66.0% in 2025, driven by the rising incidence of crimes worldwide. Advanced techniques like DNA profiling enable the identification of individuals based on their unique genetic makeup, effectively aiding crime resolution. Over the past few decades, DNA profiling has greatly impacted the criminal justice system, significantly increasing the accuracy of criminal identification. In October 2021, specialized DNA testing units were established in Mumbai, India, under the Nirbhaya scheme to address cases of sexual abuse against children and women.

Forensic Genomics Market Share

Paternity and familial testing is projected to grow at the highest CAGR from 2025 to 2033. The rise in disputes over paternity and inheritance, coupled with the growing acceptance of DNA testing for family verification, has driven demand. Additionally, advancements in DNA analysis techniques have improved accuracy and accessibility, making these tests more reliable and affordable. The integration of these services into healthcare and legal frameworks further enhances their appeal, contributing to the rapid growth of this segment in the forensic genomics market.

Regional Insights

North America dominated the forensic genomics market with the largest revenue share of 49.7% in 2025. Increasing crime rates, along with a heightened focus on solving complex criminal cases, has led to greater demand for advanced forensic technologies. Additionally, substantial government funding for forensic research and development enhances laboratory capabilities. The integration of DNA analysis in legal systems and growing public awareness of genetic testing's importance further contribute to market expansion in the region.

Forensic Genomics Market Trends, by Region, 2026 - 2033

U.S. Forensic Genomics Market Trends

The forensic genomics market in the U.S. held the largest share in the North America region in 2025. The growth of the forensic genomics market in the U.S. is fueled by rising crime rates and the need for effective crime resolution techniques. Significant government investment in forensic science and law enforcement enhances laboratory capabilities and research initiatives. The increasing integration of DNA evidence in legal proceedings underscores the importance of accurate forensic analysis.

Europe Forensic Genomics Market Trends

The forensic genomics market in Europe is experiencing growth due to several factors. Increasing collaboration between law enforcement agencies and forensic laboratories enhances the effectiveness of criminal investigations. The region's strict regulatory framework encourages the adoption of advanced DNA testing methods, ensuring high standards in forensic analysis. Rising public awareness of genetic testing for paternity and ancestry also boosts demand.

The forensic genomics market in the UK held a significant share in 2024. Strong government funding for forensic science enhances laboratory capabilities, while public awareness of genetic testing drives demand for paternity and familial testing. Collaborations between law enforcement and forensic experts further improve the effectiveness of criminal investigations.

France forensic genomics market is influenced by its unique legal framework, which emphasizes the use of DNA evidence in criminal proceedings. Recent reforms aimed at modernizing forensic practices have led to increased investment in technology and training for forensic professionals. Additionally, France's commitment to combating organized crime and terrorism drives demand for advanced forensic techniques.

The forensic genomics market in Germany is anticipated to grow significantly over the forecast period. The country has well-established protocols for DNA analysis, supported by significant investment in forensic research and development. Germany's robust legal framework facilitates the integration of advanced genetic testing in judicial processes. Furthermore, rising public interest in ancestry and genetic health testing fuels demand for forensic services, making it a key player in the European market.

Asia Pacific Forensic Genomics Market Trends

The Asia Pacific forensic genomics market is projected to grow at the highest CAGR of 15.66% over the forecast period. The forensic genomics market in Asia-Pacific is rapidly growing due to increasing urbanization and rising crime rates, which drive demand for advanced forensic technologies. Countries in the region are investing in modernizing their forensic capabilities, often supported by government initiatives aimed at improving public safety. Additionally, the rising acceptance of DNA testing for paternity and ancestral research contributes to market growth.

The forensic genomics market in China is expected to grow over the forecast period. The country is modernizing its forensic capabilities, with a focus on advanced DNA analysis technologies to enhance criminal investigations. Increasing urbanization and a growing emphasis on solving complex cases further fuel demand. Additionally, public interest in genetic testing for familial and ancestry purposes is rising, contributing to the market's growth.

Japan forensic genomics market is witnessing significant growth over the forecast period. The Japanese government actively supports the development of advanced forensic technologies, including DNA analysis, to improve public safety. Rising public awareness of genetic testing for paternity and ancestry also contributes to demand. Additionally, Japan's unique legal framework facilitates the integration of forensic evidence in court proceedings, ensuring its effective use in solving crimes.

Middle East & Africa Forensic Genomics Market Trends

The MEA forensic genomics market is projected to grow significantly over the forecast period. the rise of organized crime and terrorism has intensified the focus on advanced DNA analysis. Public awareness of genetic testing is also increasing, driving demand for services such as paternity testing. Collaborations with international forensic organizations are fostering knowledge transfer and technological advancement, further boosting the market.

Saudi Arabia forensic genomics market is set to expand in the coming years. The country is modernizing its forensic capabilities, focusing on advanced DNA analysis technologies to enhance crime-solving efficiency. Growing awareness of genetic testing for paternity and familial relationships is also driving demand. Additionally, initiatives aimed at combating organized crime and terrorism are increasing the need for reliable forensic tools, while collaborations with international forensic experts are fostering innovation and expertise in the field.

The forensic genomics market in Kuwait is also anticipated to grow in the near future. Increased investment in forensic technology, particularly in DNA analysis, is enhancing the capabilities of law enforcement agencies. Growing awareness of genetic testing for paternity and ancestry is driving public interest and demand for these services.

Key Forensic Genomics Company Insights

Companies in the market are focusing on expansion to enhance their product offerings. Additionally, many players are acquiring smaller firms to strengthen their market presence, diversify service offerings, and improve overall capabilities.

Key Forensic Genomics Companies

The following key companies have been profiled for this study on the forensic genomics market.

  • Illumina, Inc.

  • Thermo Fisher Scientific, Inc.

  • Merck KGaA

  • Agilent Technologies

  • Promega Corporation

  • QIAGEN

  • Bio-Rad Laboratories

  • LGC Limited

  • Tri Tech Forensics

  • Verogen

Competitive Benchmarking

Category

Operating Strategies

Competitive Edge

Weakness

Established Players (Illumina, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, etc.)

  • Strengthen market presence through collaborations with forensic laboratories, law enforcement agencies, and government organizations while investing in next-generation sequencing (NGS) and automation.
  • Significant R&D investments and comprehensive end-to-end forensic workflows supporting high accuracy, reliability, and regulatory compliance.
  • High dependence on government funding, public forensic infrastructure investments, and regulatory approvals.

Emerging Players (LGC Limited, Tri Tech Forensics, Verogen)

  • Expand through partnerships with forensic laboratories and by developing application-specific products tailored to criminal investigations and forensic research.
  • Strong specialization in forensic science applications with products designed specifically for forensic workflows.
  • Narrower product portfolios with greater dependence on forensic market demand and government procurement.

Recent Developments

  • In October 2024, Promega Corporation announced the development of a new enzyme that significantly reduces stutter in forensic DNA analysis. This is expected to boost the growth prospects for the company in the coming years.

  • In May 2024, QIAGEN announced a collaboration with the FBI to create a novel digital PCR assay for use with the QIAcuity platform, aimed at enhancing DNA analysis from human samples in forensic applications. This DNA quantification will enable law enforcement and forensic researchers to analyze a wider range of evidence more quickly and reliably. The partnership further solidifies QIAGEN’s leadership in human identification and forensic science.

  • In February 2024, Bode Technology advanced the field of Forensic Investigative Genetic Genealogy (FIGG) by launching a range of validated genome sequencing options, providing access to its fully accredited, in-house forensic DNA services. 

Forensic Genomics Market Report Scope

Report Attribute

Details

Market size in 2025

USD 660.0 million

Estimated market size in 2026

USD 755.6 million

Projected market size by 2033

USD 2,053.1 million

Growth rate

CAGR of 15.3% from 2026 to 2033

Historical data

2021 - 2025

Forecast period

2026 - 2033

Quantitative units

Revenue in USD million, and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, method, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Norway, Denmark, Sweden, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, Saudi Arabia, South Africa, UAE, Kuwait

Key companies profiled

Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck KGaA; Agilent Technologies; Promega Corporation; QIAGEN; Bio-Rad Laboratories; LGC Limited; Tri Tech Forensics; Verogen

Customization scope

Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Forensic Genomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global forensic genomics market on the basis of product, method, application, and region.

Global Forensic Genomics Market Report Segmentation

  • Product Outlook (Revenue, USD Million; 2021 - 2033)

    • Analyzers & Sequencers

    • Software

    • Kits & Consumables

  • Method Outlook (Revenue, USD Million; 2021 - 2033)

    • Capillary Electrophoresis

    • Next-generation Sequencing

    • PCR Amplification

    • Others

  • Application Outlook (Revenue, USD Million; 2021 - 2033)

    • Criminal Testing

    • Paternity & Familial Testing

    • Others

  • Regional Outlook (Revenue, USD Million; 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Australia

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Research Methodology

The forensic genomics market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each forensic genomics segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Segment- Product

Revenue Capture Definition

Analyzers & Sequencers

Revenue generated from instruments used to analyze, amplify, and sequence genetic material for forensic investigations. These systems support DNA profiling, human identification, kinship analysis, criminal investigations, disaster victim identification, and other forensic genomics applications by delivering accurate and reproducible genetic data.

Software

This segment captures income from bioinformatics and forensic analysis software designed for genetic data processing, sequence alignment, DNA profile interpretation, database management, mixture analysis, statistical evaluation, and forensic report generation. These solutions facilitate efficient analysis and interpretation of complex genomic evidence.

Kits & Consumables

Market value in this category stems from reagents, assay kits, extraction kits, amplification kits, sequencing consumables, sample collection amplification, sequencing, and genetic profile analysis across forensic laboratories products, and other disposable laboratory materials required throughout forensic genomics workflows. These consumables support DNA extraction, quantification,

Segment- Method

Revenue Capture Definition

Capillary Electrophoresis

Revenue generated from forensic genomics products and workflows utilizing capillary electrophoresis for the separation and analysis of amplified DNA fragments. This method is extensively employed for short tandem repeat (STR) profiling, human identification, paternity testing, and criminal investigations.

Next-generation Sequencing

This segment captures income from genomic analysis workflows based on next-generation sequencing technologies that enable high-throughput sequencing of forensic DNA samples. These methods support advanced human identification, complex mixture analysis, ancestry inference, phenotypic prediction, and degraded sample analysis.

PCR Amplification

Market value in this category stems from polymerase chain reaction (PCR)-based methods used to amplify minute quantities of DNA obtained from forensic evidence. PCR amplification plays a critical role in generating sufficient genetic material for downstream profiling, sequencing, and identification procedures.

Others

Revenue originates from alternative forensic genomics methods not classified under primary technologies, including emerging molecular biology techniques and specialized analytical approaches adopted for forensic DNA analysis and human identification.

Segment- Application

Revenue Capture Definition

Criminal Testing

Revenue generated from forensic genomics products and services used in criminal investigations for DNA profiling, suspect identification, crime scene evidence analysis, missing person investigations, disaster victim identification, and law enforcement applications.

Paternity & Familial Testing

This segment captures income from forensic genomics solutions utilized to establish biological relationships, including paternity, maternity, kinship, and other familial association analyses used in legal, immigration, and civil investigations.

Others

Market value in this category stems from forensic genomics applications outside criminal and familial testing, including wildlife forensics, anthropological studies, historical investigations, military identification, and other specialized forensic analyses.

Delivered Customizations

This report has been delivered with the following In-depth customizations

Client Request

Customization Delivered

Value Adds

Forensic Genomics Workflow & Application Cross-Segmentation Analysis

Customized cross-segmentation across products (analyzers & sequencers, software, kits & consumables), methods (capillary electrophoresis, NGS, PCR amplification), and applications (criminal testing, paternity & familial testing, others). Includes workflow-level assessment of technology adoption, product utilization, and application demand across key geographic markets.

Enables clients to identify the highest-growth technology-application combinations, evaluate product adoption across forensic workflows, prioritize R&D and commercialization efforts, and uncover high-value market opportunities across end-use scenarios.

Competitive Benchmarking of Forensic Genomics Solution Providers

Comprehensive benchmarking of leading forensic genomics companies based on product portfolio, sequencing and forensic DNA capabilities, software offerings, pricing strategy, geographic presence, distribution network, partnerships with forensic laboratories and law enforcement agencies, innovation pipeline, and strategic initiatives.

Supports competitive positioning, identifies portfolio gaps and differentiation opportunities, evaluates partnership and acquisition prospects, and helps formulate market entry and expansion strategies in the forensic genomics ecosystem.

Regional Demand & Forensic Infrastructure Opportunity Assessment

Detailed regional and country-level demand analysis covering North America, Europe, Asia Pacific, Latin America, and MEA, with assessment of forensic laboratory infrastructure, government funding, crime investigation trends, DNA database initiatives, regulatory environment, and adoption of advanced forensic genomic technologies including NGS and AI-enabled forensic software.

Helps clients identify high-growth regional markets, evaluate investment opportunities based on forensic infrastructure maturity, prioritize country-level expansion, and align product launch strategies with evolving public-sector procurement and forensic modernization initiatives.

Frequently Asked Questions About This Report

About the Author(s)

Biotechnology Research Team

Healthcare · Biotechnology

This report was authored by the biotechnology research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the biotechnology segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo